Heme oxygenase‐1 germ line GTn promoter polymorphism is an independent prognosticator of tumor recurrence and survival in pancreatic cancer

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Journal of Surgical Oncology

• Publication date

  2011-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/jso.21926PMID 21495030
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Modulation of EGFR gene transcription by secondary structures , a polymorphic repetitive sequence and mutations-a link between genetics and epigenetics

  2011cited by this paper
• Gemcitabine metabolic and transporter gene polymorphisms are associated with drug toxicity and efficacy in patients with locally advanced pancreatic cancer

  2010cited by this paper
• A genome-wide association study identifies pancreatic cancer susceptibility loci on chromosomes 13q22.1, 1q32.1 and 5p15.33

  2010cited by this paper
• Genome-wide association study identifies variants in the ABO locus associated with susceptibility to pancreatic cancer

  2009cited by this paper
• Adjuvant radiotherapy for resected pancreatic cancer: a lack of benefit or a lack of adequate trials?

  2009cited by this paper
• Heme oxygenase and renal disease

  2009cited by this paper
• Targeting of Hsp32 in solid tumors and leukemias: a novel approach to optimize anticancer therapy.

  2009cited by this paper
• Germ-line DNA polymorphisms and susceptibility to differentiated thyroid cancer.

  2009cited by this paper
• Haeme oxygenase‐1 promoter polymorphism is an independent prognostic marker of gastrointestinal stromal tumour

  2009cited by this paper
• Heme oxygenase-1 and its metabolites affect pancreatic tumor growth in vivo

  2009cited by this paper
• Single Nucleotide Polymorphisms of Gemcitabine Metabolic Genes and Pancreatic Cancer Survival and Drug Toxicity

  2009cited by this paper
• Genomic variation in myeloma: design, content, and initial application of the Bank On A Cure SNP Panel to detect associations with progression-free survival

  2008cited by this paper
• Microsatellite GTn-repeat polymorphism in the promoter of heme oxygenase-1 gene is an independent predictor of tumor recurrence in male oral squamous cell carcinoma patients.

  2008cited by this paper
• A Review on

  2008cited by this paper
• Evidence-based guidelines for adjuvant therapy for resected adenocarcinoma of the pancreas.

  2008cited by this paper
• Heme Oxygenase-1 Inhibits the Proliferation of Pancreatic Stellate Cells by Repression of the Extracellular Signal-Regulated Kinase1/2 Pathway

  2008cited by this paper
• Adjuvant therapy for pancreatic cancer

  2008cited by this paper
• Variability in reporting resection margin status in pancreatic cancer.

  2008cited by this paper
• Resection margins and R1 rates in pancreatic cancer – are we there yet?

  2008cited by this paper
• Most Pancreatic Cancer Resections are R1 Resections

  2008cited by this paper
• Treatment of pancreatic adenocarcinoma: a European perspective.

  2008cited by this paper
• Prognostic versus predictive value of biomarkers in oncology.

  2008cited by this paper
• HO-1 underlies resistance of AML cells to TNF-induced apoptosis.

  2008cited by this paper
• Pancreatic cancer: a review and update.

  2008cited by this paper
• Adjuvant Therapy for Adenocarcinoma of the Pancreas: Analysis of Reported Trials and Recommendations for Future Progress

  2008cited by this paper
• Hemoxygenase-1 in cardiovascular disease.

  2008cited by this paper
• Tumor‐Node‐Metastasis Staging of Pancreatic Adenocarcinoma

  2008cited by this paper
• Common breast cancer-predisposition alleles are associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers.

  2008cited by this paper
• Neoadjuvant and adjuvant strategies for pancreatic cancer.

  2008cited by this paper
• Increased risk of gastric cancer in Japanese subjects is associated with microsatellite polymorphisms in the heme oxygenase-1 and the inducible nitric oxide synthase gene promoters.

  2008cited by this paper
• Progress on molecular markers of pancreatic cancer

  2007cited by this paper
• Heme Oxygenase-1 in Tumors: Is It a False Friend?

  2007cited by this paper
• Guidelines for the surgical management of pancreatic adenocarcinoma.

  2007cited by this paper
• Validation of the 6th edition AJCC pancreatic cancer staging system

  2007cited by this paper
• Clinical correlates of low-risk variants in FGFR2, TNRC9, MAP3K1, LSP1 and 8q24 in a Dutch cohort of incident breast cancer cases

  2007cited by this paper
• Mechanisms of egfr Gene Transcription Modulation: Relationship to Cancer Risk and Therapy Response

  2006cited by this paper
• ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer.

  2006cited by this paper
• A microsatellite polymorphism in the heme oxygenase‐1 gene promoter is associated with risk for melanoma

  2006cited by this paper
• One Thousand Consecutive Pancreaticoduodenectomies

  2006cited by this paper
• Redefining the R1 resection in pancreatic cancer

  2006cited by this paper
• Value of preoperative serum CA 19-9 levels in predicting resectability for pancreatic cancer.

  2006cited by this paper
• Low efficacy of serum levels of CA 19-9 in prediction of malignant diseases in asymptomatic population in Taiwan.

  2006cited by this paper
• Heme oxygenase‐1 inhibits rat and human breast cancer cell proliferation: mutual cross inhibition with indoleamine 2,3‐dioxygenase

  2005cited by this paper
• Genetic Variation in the HSD17B1 Gene and Risk of Prostate Cancer

  2005cited by this paper
• Inhibition of Heme Oxygenase-1 Increases Responsiveness of Pancreatic Cancer Cells to Anticancer Treatment

  2005cited by this paper
• Molecular Basis of Heme Oxygenase-1 Induction: Implications for Chemoprevention and Chemoprotection

  2005cited by this paper
• Association of susceptibility to the development of lung adenocarcinoma with the heme oxygenase-1 gene promoter polymorphism

  2005cited by this paper
• Drug-metabolizing enzyme polymorphisms predict clinical outcome in a node-positive breast cancer cohort.

  2005cited by this paper
• Heme oxygenase-1 accelerates tumor angiogenesis of human pancreatic cancer

  2004cited by this paper
• The role of heme oxygenase-1 promoter polymorphisms in human disease.

  2004cited by this paper
• Allelic length of a CA dinucleotide repeat in the egfr gene correlates with the frequency of amplifications of this sequence—first results of an inter‐ethnic breast cancer study

  2004cited by this paper
• Host genetics and tumour metastasis

  2004cited by this paper
• Antiapoptotic role of heme oxygenase (HO) and the potential of HO as a target in anticancer treatment

  2004cited by this paper
• Genetic variants in the UDP-glucuronosyltransferase 1A1 gene predict the risk of severe neutropenia of irinotecan.

  2004cited by this paper
• Polymorphism in heme oxygenase-1 (HO-1) promoter is related to the risk of oral squamous cell carcinoma occurring on male areca chewers

  2004cited by this paper
• Upregulation of heme oxygenase-1 and p21 confers resistance to apoptosis in human gastric cancer cells

  2004cited by this paper
• Relationship between microsatellite polymorphism in the haem oxygenase-1 gene promoter and longevity of the normal Japanese population

  2003cited by this paper
• Gene regulation of heme oxygenase-1 as a therapeutic target.

  2000cited by this paper
• Modulation of EGFR Gene Transcription by a Polymorphic Repetitive Sequence – a Link between Genetics and Epigenetics

  2000cited by this paper
• Pharmacogenetics

  2000cited by this paper
• Microsatellite polymorphism in the heme oxygenase-1 gene promoter is associated with susceptibility to emphysema.

  2000influential reference
• Modulation of EGFR gene transcription by secondary structures, a polymorphic repetitive sequence and mutations--a link between genetics and epigenetics.

  2000cited by this paper
• Induction of haem oxygenase-1 by nitric oxide and ischaemia in experimental solid tumours and implications for tumour growth

  1999cited by this paper
• Pancreatic cancer: a report of treatment and survival trends for 100,313 patients diagnosed from 1985-1995, using the National Cancer Database.

  1999cited by this paper
• Treatment and survival in 13 560 patients with pancreatic cancer, and incidence of the disease, in the West Midlands: An epidemiological study

  1996cited by this paper
• Treatment and survival in 13560 patients with pancreatic cancer, and incidence of the disease, in the West Midlands: An epidemiological study

  1995cited by this paper
• d(TG)n.d(CA)n sequences upstream of the rat prolactin gene form Z-DNA and inhibit gene transcription.

  1990cited by this paper

• Emerging roles of heme oxygenase 2 (HO-2) in cancer: Implications for diagnosis and therapy.

  2025cites this paper
• The structure, folding kinetics, and dynamics of long poly(UG) RNA

  2025cites this paper
• Role of HMOX1 Promoter Genetic Variants in Chemoresistance and Chemotherapy Induced Neutropenia in Children with Acute Lymphoblastic Leukemia

  2021cites this paper
• Association between HO-1 gene promoter polymorphisms and diseases

  2021cites this paper
• Heme Oxygenase-1 Signaling and Redox Homeostasis in Physiopathological Conditions

  2021cites this paper
• The Role of Heme Oxygenase-1 Promoter Polymorphisms in Perinatal Disease

  2021cites this paper
• The Diverse Roles of Heme Oxygenase-1 in Tumor Progression

  2021cites this paper
• Transition metal dichalcogenides as ultrasensitive and high-resolution biosensing nodes

  2020cites this paper
• Role of heme oxygenase 1 and human chorionic gonadotropin in pregnancy associated diseases.

  2020cites this paper
• Association between heme oxygenase-1 gene promoter polymorphisms and cancer susceptibility: A meta-analysis

  2018cites this paper
• Heme oxygenase inhibition in cancers: possible tools and targets

  2018cites this paper
• Emerging novel prognostic markers in pancreatic ductal adenocarcinoma

  2018cites this paper
• Association of the microsatellite (GT)n repeat polymorphisms of the HO-1 gene promoter and corresponding serum levels with the risk of laryngeal squamous cell carcinoma

  2016cites this paper
• Role of Nrf2/HO-1 system in development, oxidative stress response and diseases: an evolutionarily conserved mechanism

  2016cites this paper
• Nanofabrication and Characterization of Nanoelectronic Biosensors Based on Emerging Layered Semiconductors.

  2016cites this paper
• Multiple MoS2 Transistors for Sensing Molecule Interaction Kinetics

  2015influential citation
• Heme oxygenase-1: emerging target of cancer therapy

  2015cites this paper
• Association of heme oxygenase-1 polymorphisms with cancer risk: A systematic review and meta-analysis.

  2015influential citation
• A Preliminary Study on Racial Differences in HMOX1, NFE2L2, and TGFβ1 Gene Polymorphisms and Radiation-Induced Late Normal Tissue Toxicity.

  2015cites this paper
• Effect of Tumor Necrosis Factorα on Expression of Heme-Oxgenase 1 in Human Gingival Fibroblasts

  2015cites this paper
• Effect of Tumor Necrosis Factorα on Expression of Heme-Oxgenase1 in Human Gingival Fibroblasts

  2014cites this paper
• Upregulation of heme oxygenase-1 in colorectal cancer patients with increased circulation carbon monoxide levels, potentially affects chemotherapeutic sensitivity

  2014cites this paper
• Oncogenic potential of Nrf2 and its principal target protein heme oxygenase-1.

  2014cites this paper
• Zinc protoporphyrin IX enhances chemotherapeutic response of hepatoma cells to cisplatin.

  2014cites this paper
• GT Microsatellite Repeats in the Heme Oxygenase-1 Gene Promoter Associated with Abdominal Aortic Aneurysm in Croatian Patients

  2013cites this paper
• Radical Decisions in Cancer: Redox Control of Cell Growth and Death

  2012cites this paper
• The Multiple Functions of Heme Oxygenase-1 in the Liver

  2012cites this paper
• Selective inhibition of hemeoxygenase-1 as a novel therapeutic target for anticancer treatment

  2011cites this paper
• Faktor Prediktif Rekurensi Dini Adenokarsinoma Pankreas Setelah Bedah Reseksi Kuratif: Systematic Review

  year unknowncites this paper